Mark Behrman
Analyst · Sidoti & Company. Please go ahead
Page 10 of the presentation, thank you, John. Page 10 of the presentation provides a consolidated summary statement of operations for the fourth quarter of 2016 as compared to 2015. In reviewing our continuing operations, total net sales and gross profit were down for the quarter primarily related to lower selling prices across our key agricultural product groups partially offset by higher production and sales volumes at each one of our facilities. In addition to lower selling prices gross profit declined versus the fourth quarter of 2015 as we incurred $8.5 million in additional depreciation expense in Q4 2016. A new ammonia plant at El Dorado went into production in mid year and we began depreciating that asset after entered service. Offsetting these two factors with improved production we have better absorption of fixed cost at all of our facilities lower plant fixed cost and lower feed-stock cost. As we discussed in the third quarter we implemented in the expense reduction program with the goal of reducing SG&A expenses by approximately $6 million annually. That goal was achieved and we are seeing some of the cost savings come through in this fourth quarter as consolidated SG&A was down approximately $4 million as compared to the fourth quarter of 2015. Approximately $3 million of the reduction is related to personnel cost reductions. Our current SG&A run rate is now between $30 million and $35 million for the year. You will note that we took impairment charge of $1.6 million during the fourth quarter of 2016. This represents the non-cash write-off of goodwill that was created when we purchased El Dorado in early 1980s. Interest expense for the quarter increased approximately $9 million over Q4 2015 as we stopped capitalizing interest related to the expansion at El Dorado when our new ammonia plant began operating midyear. As we previously announced we repaid $100 million of our debt in October from proceeds from the sale of our climate control business. As a result we recognized a loss on extinguishment of debt of approximately $8.7 million that is reflected in the separate line item on our income statement. Lastly adjusted EBITDA was $2.8 million for the quarter a $5.3 million improvement versus Q4 2015 EBITDA loss of $2.5 million. This also compares favorably to the fourth quarter EBITDA guidance I gave last quarter as part of our Q4 cash flow outlook which forecast an EBITDA loss for the quarter of between $3 million and $5 million. The improvement in actual EBITDA versus forecast was primarily driven by improved operating rates that yield better fixed cost absorption and provided more products for sale. Please refer to our reconciliation of non-GAAP measures beginning on slide 17 for further information on non-cash and onetime cost incurred during the period. In order to give further clarity on the results of the quarter page 11 bridges our consolidated adjusted EBITDA for Q4 2015 to Q4 2016. As I mentioned earlier lower selling prices of our products was a big drag on EBITDA as they had a negative impact of more than $15 million compared to Q4 2015. However, improved sales volume of products for the quarter provided an additional $11 million of EBITDA. The sales volume increased was driven by better onstream rates of Pryor and Cherokee versus Q4 2015 improved sales of HDAN as we broaden our distribution of that product increased ammonia sales as the new ammonia plan at El Dorado was producing during the quarter it was not yet in operation in Q4 2015 and increased sales of our acid products. With improved onstream rates yielding improved production during the quarter versus Q4 2015 we had significantly better absorption of our fixed cost. That coupled with the reduction in plant fixed cost versus the fourth quarter of 2015 resulted in an improvement in EBITDA of over $8 million. As we have discussed previously there are several benefits to the new ammonia plant at our El Dorado facility. During the quarter we picked up approximately $6 million in EBITDA by producing our own ammonia versus previously purchasing it. As we have also previously discussed, we incurred repair and restore cost due to issues at our nitric acid plant at El Dorado facility. These cost negatively impacted EBITDA during the quarter by approximately $2.3 million. Since we restarted the nitric acid plant in November we stopped incurring any of these costs. We do not anticipate incurring these going forward. We believe that we will be able to recoup most of all of these cost under warranty, we have expensed them to be conservative. As John mentioned earlier during the quarter we experienced some downtime at our El Dorado ammonia plant during the shakedown period. As a result we incurred cost related to repairs and had to purchase some ammonia to cover sales. That resulted in a reduction in EBITDA of $4 million and lastly lower corporate overhead contributed to the balance of the year-over-year EBITDA improvement. The right hand column of this page reflects normalized EBITDA by assuming that selling prices are consistent in each period and excluding the cost incurred related to the nitric acid and ammonia plants at El Dorado as we should not incur this cost moving forward. Well we recognized product selling prices move with general market conditions this analysis provides a view of the operational improvement activities that we have undertaken. The EBITDA improvement quarter-over-quarter was $26.8 million improvement showing significantly improved operations. Page 12 outlines our capital structure as of year-end 2016. We ended the year with $60 million in cash, which was higher than our previous outlook for cash that we gave during Q3 2016 earnings call as we had better than expected EBITDA, an earlier closing on a sale of a non-core asset and a tax refund which we didn’t forecast. Additionally, our ABL facility was undrawn and had $35.7 million of availability. We remain undrawn on our ABL facility and as of January 31, 2017, we continue to be undrawn and as a result of increased sales, we had $40.5 million of availability. During the quarter, we repaid a $100 million of senior secured notes and as a result we now have $375 million in senior secured notes outstanding. That combined with other debt of approximately $53 million, left us with a total outstanding debt at year-end of approximately $428 million, excluding the unamortized discount and issuance cost associated with our debt. We also had outstanding preferred stock of approximately a $162 million including approximately $22 million in accrued and unpaid dividends. For 2017, we currently expect to continue to accrue the dividends in our preferred stock as we do not need the to-do on fixed charge coverage ratio and needed to make restricted payments. However, should coverage trends in our end-markets continue, we will consider using excess cash to reduce leverage either through the repayment of debt or if we meet the required fixed charge coverage ratio, the payment of accrued dividends. Moving to page 13, we outline our free cash flow. The significant net income for the first 12 months of this year relates to the gain on the sale of our climate control business. Backing that out, we used approximately $22 million for operations for the year. We had significant capital expenditures during the year of given the completion of the full El Dorado expansion project in the second quarter of this year, we are now back to incurring maintenance capital expenditures as we encourage slightly over a $11 million in CapEx during Q4, 2016. As we have stated previously, going forward, we expect to incur maintenance capital expenditures up $30 million to $35 million that will focus on enhancing the safety and reliability of all of our plans. Net cash use by financing primarily reflects to redemption of preferred stock in the senior secured notes that occurred during the year. Please turn to page 14, while I'll discuss our outlook for 2017. In addition to our outlook for sales volume by product, depreciation and interest expense, which we have provided in previous quarters, this quarter we have added additional operating and financial metrics that we believe provide more transparence to help in understanding our business. Since, 2015 and 2016 were a transition period for LSB, the historical results from these years are not particularly useful in projecting what our future performance should look like under more stead state operations. The matrix we're providing on slide 14 and 15 are meant to service points of reference for how we currently are thinking about our targets for 2017. We try to capture potential variation in factor such as demand, on-stream rates and cost levels by using ranges. With that said, we do not plan to provide updates to all of these metrics on a quarterly basis, with the exception of sales volumes or if there was a substantial change to our view on one of the other items. Product sales volumes for the full-year of 2017 are presented on the top half of the page. As a result of improved operating rates at all of our plants, aggressive marketing of HDAN and nitric acid and mixed acids at the El Dorado ammonia plant operating for a full-year. All product sales volumes with the exception of AN solution are higher than corresponding product sales volumes for 2016. You will notice that we have separately identified nitric acid sales at Baytown. As many of you know, we managed the Baytown facility on behalf of Cogestro and received management fees for managing the operations and marketing nitric acid at that facility. Our agreement instructions said we record all nitric acid sales and cost of sales for product sold out of that plant, including the full cost of purchased ammonia. In effect, our financial statements reflect a gross up of sales and cost of sales. Therefore, when thinking about profitability for managing the Baytown facility, EBITDA has traditionally been between $4.5 million and $5.5 million annually, which represents a high-single digit EBITDA margin on that business. On the operations front, as John has previously mentioned, given the CapEx we have invested over the last four years including the work done last fall, we are expecting out three ammonia plants to operate on an average on-stream rate of 95% for the full year. Based on that, we are expecting to produce between 780,000 tons and 820,000 tons of ammonia for the year. As far as turnarounds for the year, we have only one schedule at Pryor which will be in the fourth quarter of 2017 and is expected to last 21 days. The approximate expense of that turnaround will be about $2 million. Turning to the financial outlook for 2017 on page 15, we have provided additional financial metrics including wearable and fixed cost which we believe provide additional clarity when looking at our business. Many of you have asked about fixed plan costs and we have provided a range for those costs for 2017. We have identified certain fixed and variable cost that we believe we can reduce. We'll be working on reducing those cost this year, but we have not included any reductions in the expense ranges provided. Lastly, I discussed last quarter that we identified certain non-core assets that we expect to sell on 2017 for net cash proceeds of between $20 million and $25 million. During Q4 2016, we sold some idle equipment for approximately $5 million in net proceeds, leaving us additional assets to sell in Q1 and Q2 of 2017 that will generate between $15 million and $20 million in net cash proceeds. We are currently in negotiations in all of these assets. 2016 was a transition year for us. Our main goals for to complete the El Dorado expansion to continue to improve the reliability of all of our plants and to increase the sales and distribution of our products. We incurred numerous cost last year, to start up our new ammonia plants at El Dorado to make repairs to our new nitric acid plant at El Dorado that we believe will be reimbursed under warranty. For additional plant expenses related to shake down the issues after the startup of our new ammonia plant at El Dorado and for extended turnarounds at Cherokee in Pryor. We believe all of these issues are behind us. We are excited about our prospects for 2017 as our forward sales orders for UAN and HDAN stretched into the second quarter at prices that are more favorable than what we saw at the end of '16 and at the start of this year. We believe that we will generate EBITDA for the year that more than covers the top end of our outlook range for interest expense and CapEx for the year and that our Q1 2017 EBITDA will exceed the adjusted EBITDA we had for Q1 2016 despite a much lower current selling price environment compared to Q1 2016. On page 16, we provide an EBITDA sensitivity analysis table. Many of you have seen this before but in the past it only represented our chemical business. This table now reflects sensitivities to consolidated EBITDA which includes all corporate expenses. Please keep in mind that this table includes some assumptions. First, the Tampa ammonia price represents an average price for the full year. Second, it assumes that we are operating at close to desired on-stream rates which we expect to achieve over the next 12 to 18 months. Lastly, it assumes the consistent correlation between ammonia, UAN and HDAN which at times may not be the case. We believe that the sensitivity analysis reflects the earnings power of our business and shows that we have significant operating leverage from improved operations and increased product selling prices. I'll now turn it back over to Dan to wrap up.